Volume 5 Supplement 1

Proceedings of the Bio-Ontologies Special Interest Group 2013

Open Access

Preserving sequence annotations across reference sequences

  • Zuotian Tatum1, 4Email author,
  • Marco Roos1, 2,
  • Andrew P Gibson1,
  • Peter EM Taschner1,
  • Mark Thompson1,
  • Erik A Schultes1 and
  • Jeroen FJ Laros1, 3
Journal of Biomedical Semantics20145(Suppl 1):S6

DOI: 10.1186/2041-1480-5-S1-S6

Published: 3 June 2014

Abstract

Background

Matching and comparing sequence annotations of different reference sequences is vital to genomics research, yet many annotation formats do not specify the reference sequence types or versions used. This makes the integration of annotations from different sources difficult and error prone.

Results

As part of our effort to create linked data for interoperable sequence annotations, we present an RDF data model for sequence annotation using the ontological framework established by the OBO Foundry ontologies and the Basic Formal Ontology (BFO). We defined reference sequences as the common domain of integration for sequence annotations, and identified three semantic relationships between sequence annotations. In doing so, we created the Reference Sequence Annotation to compensate for gaps in the SO and in its mapping to BFO, particularly for annotations that refer to versions of consensus reference sequences. Moreover, we present three integration models for sequence annotations using different reference assemblies.

Conclusions

We demonstrated a working example of a sequence annotation instance, and how this instance can be linked to other annotations on different reference sequences. Sequence annotations in this format are semantically rich and can be integrated easily with different assemblies. We also identify other challenges of modeling reference sequences with the BFO.

Background

Sequence annotations and their relationship with reference sequences

Sequence annotations are information artifacts that add biologically meaningful information to specific locations on genomic, gene, transcript or protein sequences. For example:
  1. 1)

    Gene OR4F5 is located on human chromosome 1 (build hg19), from position 69090 to 70008.

     
  2. 2)

    Substitution of C by T at location 178 of transcript reference sequence NM_004006.2 results in nonsense variant Gln60* in protein reference sequence NP_003997.1.

     

Sequence annotations are only meaningful if the reference sequence is known. However, specifying a stable reference is not necessarily straightforward. Before the Human Genome Project, Locus Specific Databases (LSDB) were recommended for storing and sharing gene centric variant annotations [1]. To date, the most popular platform for storing these transcript variants is the Leiden Open-source Variation Database v.2 (LOVD2) [2]. In each LOVD2 instance, a "stable" transcript sequence is chosen as the reference sequence of each gene. Variants are annotated with descriptions of sequence variations and positions according to the chosen transcript sequence. There are many advantages of using gene/transcript centric annotation approach. First, the length of a gene is much shorter than a locus/chromosome, therefore maintaining the sequence content is much easier. Secondly, it limits annotations mainly to the protein coding regions of the genome, therefore focusing more on easy to predict phenotypic effects. However, LSDBs typically limit descriptions of DNA variants to a single transcript, even when multiple transcripts may be affected. Depending on which transcript is used, the variant description may look very different. To calculate the location of a variant based on a different reference sequence, an external conversion tool has to be used for the position conversion [3]. Disambiguation of the variant description is an essential step in the context of data integration and preservation.

However, not all biological questions are locus specific. As sequencing technologies advanced in the past 15 years, more and more studies are omics focused, requiring a "stable" and "complete" reference genome [4]. The Human Genome project was completed in April 2003, followed by the release of human genome assembly NCBI35/hg17 in May 2004. Sequence gaps and assembly errors were removed and newly discovered genes, (non-coding) transcripts and proteins were annotated with every new release up to GRCh37/hg19 (February, 2009) [5]. As reference sequences are revised, it becomes increasingly difficult to track and compare annotations. Researchers today share their results of genome-wide genomic and epigenetic studies in publications and databases, but they often fail to mention the exact version of the reference genome sequence. Moreover, many popular annotation file formats do not explicitly ask for reference sequence version information. It is up to the user to embed this information in the file description through natural language. Consequently, when using these formats to exchange data for computational analysis and data integration, essential metadata is too easily lost. For example, the ENCODE Project Consortium [6] has effectively shared their data by publishing them as annotation tracks in the UCSC genome browser [7]. However, these annotation tracks use Browser Extensible Data (BED) format, which does not explicitly state the reference assembly version within the file. To propagate current annotations to the forthcoming GRCh38/hg20 and alternative genome assemblies, it is crucial to preserve annotations with their respective reference sequence versions.

A Semantic Web approach to data integration

A possible approach to exposing sequence variation annotations in a computer accessible format is provided by Sematic Web languages and tools [8]. It effectively removes the boundaries between annotating data, linking data, and making data machine readable [911]. By representing data and metadata in Resource Description Framework (RDF) and using shared ontologies in RDF and Web Ontology Language (OWL), mismatches between database schema's and the identity of its content can be addressed [12, 13]. A first attempt for mutation data was presented by Zappa and coworkers, who produced a mutation database for TP53 as Linked Open Data [14]. They followed the principles of Linked Data [15] and applied various existing ontologies to achieve optimal interoperability. However, they did not address the problem of integrating mutation data that were annotated using different reference sequences. They did not model genomic locations of annotations in detail, which makes querying this dataset difficult.

Ontological framework for data integration across resources

Formal ontologies play an important role in semantic data integration between information systems [16, 17], bringing conceptual coherence, stability, and scalability to the applied domain, which can greatly increase data interoperability [17, 18]. The Open Biological and Biomedical Ontologies (OBO) Foundry provides a suite of orthogonal interoperable ontologies to aid knowledge integration in the biomedical domain [19]. To take advantage of the OBO Foundry ontologies, we have chosen Basic Formal Ontology (BFO) [20] as our upper ontological framework for data modeling [20]. Other ontologies in OBO that are relevant to this paper include the Information Artifact Ontology (IAO) [21], the Sequence Ontology (SO) [22], the Ontology for Genetic Interval (OGI) [23], and the Relation Ontology (RO) [24].

Previous efforts on modeling biological sequences and sequence annotations in the OBO community have taken primarily a biological viewpoint. Thus, sequences refer to biological molecules, and sequence annotations refer to features defined with respect to biological process [22, 25]. The SO focuses on creating a set of consistent vocabularies that describe the biological functions of these sequences and defining the biological relationships between these sequences [22]. OGI models the biological physical sequence by adopting the realism approach from BFO, and further contributes to this model by adding spatial topological relationships between sequences [23]. However, Hoehndorf et al. pointed out a gap between this biological model and information systems that are used to store sequence annotations [26]. To bridge this gap, they have proposed three views of biological sequences: molecular, syntactic, and abstract. Molecular sequences are DNA and RNA molecules as well as proteins. Syntactic sequences are strings like "ACAC" and represent the arrangement of the molecules in the molecular sequences. Abstract sequences represent an equivalence class of sequence tokens or representations. They point out that without such a clear distinction data integration is hampered. Indeed, the SO community acknowledged the lack of distinction that is made by biologists between abstract, syntactic, and molecular sequences. Bada and Eilbeck proposed a strategy of separating SO into two parallel ontologies: one for molecular sequences, the other with abstract sequences (abstract in a broader sense than meant by Hoehndorf). The former would be an extension of the Molecular Sequence Ontology while the SO would focus more on the abstract sequences referring to sequences, and parts of sequences [27]. However, this new alignment strategy is still under discussion.

Beyond the OBO Foundry there are additional relevant ontologies applicable to sequence annotation. The Feature Annotation Location Description Ontology (FALDO) is the latest effort to address the void of describing sequence annotations from the information systems' perspective [28]. It is designed to be general enough to describe annotations with various level of location complexity, but not addresses issues such as the meaning of or the evidence of the location.

Aim of this paper

Our aim is to create an RDF data model for describing sequence annotation instances within an established ontological framework that fits our practice of working with reference sequences and different versions of genome assemblies. We provide a mechanism for linking annotation instances to different reference sequences. We also present some of the challenges in aligning our approach with current OBO Foundry ontologies.

Results and discussion

Describing sequence annotation instances

Our starting point for modeling sequence annotations was the BED format, a widely used table-based format for sequence annotations that is easy to use and efficient to store (see Figure 1). It typically consists of rows with a reference (e.g. a chromosome identifier), start and end position on that reference, and a value for the annotation. Most UCSC genome browser annotations can be downloaded as BED tracks. We started by deriving our RDF model from the BED format: (i) we identified the desired upper ontological framework for the domain of interest; (ii) we converted data in the BED track to RDF triples; (iii) we further transformed the resulting triples by adding class definitions and ontology mappings to the final model. We describe these steps below:
Figure 1

BED file examples. RefSeq transcript annotation in BED format on genome builds hg19 (a) and hg18 (b). The second line contains the start and end positions of the NM_001005484 transcript encoded by the OR4F5 gene that differ per assembly. Note that the BED file header line does not explicitly state the reference sequence information. The submitter can only embed this information in the track description through natural language.

Upper ontological framework

We chose to use the BFO (version 1.1) as our top-level ontological framework. We augmented BFO with a minimal Reference Sequence Annotation (RSA) ontology to capture classes and predicates, and defined alignment strategies for RSA with OBO.

Data transformation to triples

As a preparative step, we first created annotation instances that closely matched our original data format. We created a 'naive' model for sequence annotation to directly translate the information in the BED file with the addition of the reference assembly name (Figure 2). Predicates linking the resource and its property values were derived from the BED format description. At this stage, we used rdfs:Literal to capture concepts without further ontological grounding (i.e., rdf:type relations). This data-centric approach to semantic modeling is similar to the 'syntactic' conversion that is often used for integration of non-RDF resources, where table values are converted to literals, and table names and headers to classes and properties without any further semantic modelling [29]. These naive models usually have limited semantic depth, such that finding common elements for integration with other data sources can be difficult. Therefore, the model is often linked to a more sophisticated, or personal model. In our case, we used the naive model as a starting point in the modeling process, replacing it step by step by a more precise model (Figure 3). Content of rdfs:Literals from the naive model were thus converted to owl:instances, and class definitions were added. Below, we discuss our derivation of the new model step-by-step, while explaining the placement of new RSA classes and predicates, the reuse of existing ontologies, and potential problems with OBO alignment. An RDF representation of the final model is shown as follows:
Figure 2

Naive model. Naïve transformation of a BED sequence annotation. Predicates used in this model are placeholders and replaced in a later stage.

Figure 3

Semantic model. A sequence annotation instance after semantic transformation.

@prefix xsd: <> . http://www.w3.org/2001/XMLSchema#

@prefix rsa: <> . http://rdf.biosemantics.org/ontologies/rsa#

@prefix hg19: <> . http://rdf.biosemantics.org/data/genomeassemblies/hg19#

@base <> . http://rdf.biosemantics.org/examples/sequence_annotation#

:transcript a rsa:SequenceAnnotation ;

    rsa:refseqID "NM_001005484";

    rsa:isAnnotatedAt :location .

:location a rsa:AnnotationLocation ;

    rsa:start "69090"^^xsd:int ;

    rsa:end "70008"^^xsd:int ;

    rsa:mapsTo hg19:chr1 ;

    rsa:hasOrientation rsa:forward

hg19:chr1 a rsa:ReferenceSequence ;

    ro:integral_part_of hg19:assembly .

hg19:assembly a rsa:ReferenceAssembly .

Modeling locations on a reference sequence

We considered two approaches to harmonizing genomic location across different reference sequences. On the one hand, one may consider the location as an integral part of the annotation. That is, if the location is changed, the annotation becomes a different annotation. For example, variant annotations generally include the location of the annotation as part of the identifier. Thus, the change of location results in change of identifier of the annotation. On the other hand, a location can be considered an instance separate from the annotation. In this way, a single annotation can be associated with multiple locations and a single location can be associated with multiple annotations. In our example, the second approach is more appropriate because it provides a mechanism to link an annotation to locations on different reference sequences and sequence assemblies. Therefore, we created an instance of RSA:AnnotationLocation :region, as the subject of positional properties. We defined the instance of hg19:assembly and hg19:chr1 as ro:integral_part_of hg19:assembly. We linked :region to hg19:chr1, which indirectly linked this annotation with the reference assembly.

In the example shown in Figure 3, we kept the :start and :end as rdfs:Literals. It is also possible to convert the values of :start and :end to rdfs:Resource, and assign values to these resources. However, we argue that :start and :end should be treated as data type properties of a region. By doing so, we discourage linking of other RDF resources to :region boundaries and the smallest linkable resource remained to be :region. Furthermore, in practice, using rdfs:Resource to describe the start and end of a region (simply two numbers) leads to an explosion of triples. Hence, our model expresses instance data in its simplest form. In contrast, FALDO defines :start and :end as instances of faldo:Positions. It uses more triples (12 instead of 2) to describe the two points. A benefit of FALDO's approach is that it gives more flexibility to describe fussy regions.

Model strand-ness of sequence features

In contrast to RNA and protein, the stranded-ness of DNA sequences needs to be addressed when modeling DNA sequence annotations. Because the two DNA strands are the reverse complement of each other, information encoded in one orientation can be derived from the other strand. Consequently, sequence records in DNA databases contain only one of the two DNA strands (as the other stand can be inferred), but this does not necessarily mean this is the strand an annotation pertains to. We have to take this into account when modeling the strand in an annotation.

When annotations are only linked to the reverse strand of a reference sequence, there are two conceptual annotation models. "Reverse strand annotations" can be understood either as annotations on a sequence that is the reverse complement of a reference sequence, or they can be understood as annotations on the reference sequence, but their interpretations are based on the reverse complement. In the first conceptualization, we need to link an annotation instance to a new sequence instance that is the reverse complement of a known reference sequence. In the second conceptualization, the reverse-ness is a quality of the annotation similar to length being a quality of a region. In practice, most sequence annotation systems specify coordinates using one strand as reference (the forward strand) and "strand" or "orientation" to indicate which strand an annotation pertains to. Thus, the stranded-ness in our example data refers to how annotations can be interpreted on single strand sequences. We modeled this in our example RDF with :hasOrientation :forward.

We further argue that orientations of annotated regions are not limited to :forward and :reverse. If an annotation represents a sequence feature of both strands, such as a CpG Island, we consider the orientation of an annotation as :bidirectional. If the reference sequence is a syntactic sequence representing single strand molecules (RNA, protein), or if the sequence feature does not rely specifically on the underlying sequence (as in the case of a specific binding or chromatin features), the annotation orientation is :none. As a result, the class for annotation orientation is defined as an enumeration of four disjoint instances.

RSA:Orientation subclass of

    { RSA:forward, RSA:reverse, RSA:bidirectional, RSA:none } .

RSA classes and alignment with OBO

We have created instances using five classes from RSA. To enable better integration of our data to existing linked data, we considered how to align RSA classes with OBO classes.

RSA:SequenceAnnotation can be regarded as an SO:sequence_feature with an annotated location on a reference sequence. However, SO is currently not directly aligned with BFO, although this is an ongoing effort [25]. To further improve the consistency and interoperability of SO, new approaches to the BFO alignment were proposed. Terms in SO could be distinguished as either molecular sequences (BFO:independent_continuant, IC) or abstract sequences (BFO:generically_dependent_continuant, GDC) representing molecular sequences [27]. This distinction provides a foundation for the alignment between SO and BFO. Following the same alignment strategy, we chose to refer to SO:sequence_feature as a subclass of GDC. While it is not necessarily true that all terms under SO:sequence_feature can be GDCs, it is outside the scope of this paper to define which section of SO:sequence_feature falls into GDC. Because RSA:SequenceAnnotation is an information entity, we also considered to use IAO:information_content_entity as its super class. However, it is not clear to us whether a class can be the subclass of both SO:sequence_feature and IAO:information_content_entity, because the definition of SO:sequence_feature under GDC is still under discussion. We therefore defer the alignment between RSA:SequenceAnnotation and IAO:information_content_entity to the alignment between SO and IAO. Meanwhile, IAO provides a useful link between database row instances and annotation instances. For example, an instance of RSA:SequenceAnnotation can be the object of IAO:is_about.

To summarize, we defined RSA:SequenceAnnotation as a subclass of BFO:generially_dependent_continuant, and in particular,

RSA:SequenceAnnotation subclass of

    SO:sequence_feature and

    RSA:isAnnotatedAt some RSA:AnnotationLocation

RSA:AnnotationLocation is a constraint on a reference sequence in terms of location and orientation, with data properties such as a start point and an end point. We argue that it should be classified as a GDC in BFO, because it cannot exist outside the context of an annotation of a reference sequence. However, this prevents alignment with other relevant classes in OBO. For instance, OGI:Biological_interval provides the location properties and it defines relationships between two instances of intervals such as by OGI:isLocatedBefore. Nevertheless, OGI:Biological_Interval is defined as the "spatial continuous physical entity" and a subclass of BFO:object, and thus a subclass of IC. In the context of sequences, this defines an interval as a molecular sequence. Therefore, we only defined relationships between the orientation, the reference, and the annotation location in the scope of RSA.

RSA:AnnotationLocation subclass of

    RSA:hasOrientation some RSA:Orientation and

    RSA:mapsTo some RSA:ReferenceSequence

RSA:ReferenceSequence is about biological sequences, and modeling biological sequences in ontologies is not easy [26]. In RSA, we defined RSA:ReferenceSequence as a syntactic sequence. This is an information-bearing entity that contains a series of letters from a given alphabet (i.e., ATGC for DNA). It can represent sequential information captured by a biological molecule, but may represent a (possibly empty) set of molecules. It can be stored in computer systems or on a piece of paper, therefore its physical existence is an instance of IAO:information_content_entity. To correctly model reference sequences, it is crucial to distinguish between the sequence content and the file storing the sequence content, and therefore define RSA:ReferenceSequence not a subclass of IAO:information_content_entity. For example, both transcript sequences and chromosome sequences can be used as reference sequences, so instances of RSA:ReferenceSequence can be ro:proper_part_of another instance. This part of relationship is important for data integration scenarios shown in the next section, and this part of relationship works only if RSA:SequenceAnnotation is defined by the sequence content, as the sequence content of a transcript can be part of the sequence content of a chromosome. However, if RSA:ReferenceSequence is defined as a subclass of IAO:information_content_entity, the part of relationship cannot be modeled because the file of a transcript sequence is not part of the file of the chromosome sequence.

In addition, we were confronted with the limitations of the reality constraint of BFO [30]. In the field of sequence annotations, biologists often work with abstract entities that only have an indirect relation to entities that exist in reality. For instance, the notion of a consensus sequence is widely used in practice. Consensus sequences are hypothetical sequences designed to capture information not from single molecules, but from sets similar molecules. In the case of reference sequence modeling we must accommodate consensus sequences. If we modeled RSA:ReferenceSequence as a subclass of GDC, the instance hg19:chr1 (chromosome 1 in human genome assembly version 19) inheres in an instance of a corresponding molecular sequence. However, there is no molecular sequence that corresponds with the sequence content of hg19:chr1, because hg19:chr1 is the consensus of the sequence content of chromosome 1 of multiple people. The consensus sequence modeling problem not only applies to sequences in genome assemblies, but also to all sequences generated by Next Generation Sequencing technologies. Even in the context of personal genome sequencing, a sequence may not be derived from a single molecule from a single cell, but from a set of molecules from multiple cells. As discussed by Hoehndorf et al., proper definitions of biological sequences require the upper ontological framework to handle hypothetical sequences [26]. Thus, we argue that how to define a consensus sequence within the framework of BFO and OBO needs to be addressed by the OBO community. SO provides class SO:consensus_region for consensus sequences. However, this class is not aligned with BFO, and it is unclear whether this class is designed with OBO principles.

Finally, RSA:ReferenceAssembly is an information entity encapsulating a set of RSA:ReferenceSequence s that are often used together to represent the total sequence content of an organism, and RSA:ReferenceSequence is RO:proper_part_of RSA:ReferenceAssembly. Its version number (in some cases, the timestamp) is crucial for data integration. RSA:ReferenceAssembly cannot be aligned with BFO, because its parts are not aligned with BFO.

Semantic relations between annotations

With a complete ontological framework in place, we then investigated how sequence annotations using different reference sequences can be semantically linked. Semantic relationships between sequence annotations are determined by the relationship between their reference sequences. We categorized three types of reference sequence relationships that are crucial for data integration: 1) The two reference sequences represent the same biological entity; 2) One reference sequence is a syntactic part of the other reference sequence; 3) One reference sequence can be syntactically derived from the other reference sequence. Here, we show how each reference sequence relationship defines the relationship between annotations in Figure 4.
Figure 4

Semantic relationships between annotations. The sematic relationship between annotations is determined by the relationship between their reference sequences. 1) An annotation is the same as another annotation if their reference sequences represent the same biological entity. 2) An annotation is equivalent of another if its reference sequence is syntactic part of the other reference sequence. 3) An annotation is derived from another if it reference sequence is derived from the other reference sequence.

The same as relationship is important for integrating annotations based on different reference assemblies (Figure 4A). For example, the gene annotation of OR4F5 based on hg19 is the same as the one based on hg18. We note that the properties of the underlying reference sequence may differ, and hence the two annotations may have different properties (the start and end points on chromosome 1), but they share the same identifier (OR4F5). The equivalent relationship is important for integrating annotations with different sequence features (Figure 4B). For example, the variant annotation NM_004006.2:c.178C>T is equivalent to variant annotation NC_000023.10:g.32867853G>A. Although these two variant annotations are defined by different positions and different nucleotide substitutions, they describe the same biological variation from two different viewpoints. The c. notation uses transcript as the reference sequence and captures the effect of variation on RNA, whereas the g. notation uses chromosome as the reference sequence, and captures the effect on the genome. The derived from relationship is important for connecting annotations that occurred in different biological processes (Figure 4C). For example, variant annotation on the protein level NP_003997.1:p.Gln60* is derived from variant annotation on the transcript level NM_004006.2:c.178C>T.

Interoperability across reference assemblies

To define the relationship between reference sequences from different reference assemblies is not trivial. In line with semantic data integration strategies [29], our goal was to define the common domain of integration across reference assemblies at the chromosome level. However, this domain of integration is outside the scope of RSA. Modeling the relation between consensus sequence and chromosome in line with BFO was not straightforward. In this section, we present three possible methods to connect reference sequences across assemblies.

The first method uses the 'inheres in' property to relate the two instances of class Chromosome 1 that then represent the common domain (Figure 5A). This approach seems to follow BFO. However, we did not find an existing superclass for Chromosome 1, because hg19:chr1 and hg18:chr1 are consensus sequences that do not inhere in any particular chromosome. The superclass for Chromosome 1 would require an equivalent of a consensus chromosome that is a subclass of IC, which we have shown in the last section is not currently possible.
Figure 5

Domain of integration models. Three ways to link reference sequences. A) Linking two reference sequences via two molecule instances of the same class. B) Linking two reference sequences via a single class. C) Linking reference sequences via an instance of abstract chromosome.

The second method is perhaps the least attractive, because it defines a relationship between an OWL:Individual and an OWL:Class that is not a class assertion, violating the OWL-DL definition and making reasoning over datasets undecidable. However, this method eliminates the need for 'real chromosome instances' required by the 'inheres in' relationship in the first method (Figure 5B).

The third method uses a single instance of an abstract class Chromosome 1 (Figure 5C), using the Genome Component Ontology (GCO). GCO does not follow BFO's realism viewpoint, and is intentionally kept as minimal as possible. It defines the abstract division of the total genetic information of an organism by its physical separation into different components, but not to describe any specific characteristics derived through experimentation. Instances of GCO:GenomeComponent provide high level references. More specific descriptions, such as gene content, length, function, location, loci or sequence, can be linked to instances representing instances of GCO:GenomeComponent.

Each method has advantages and disadvantages. We consider method 3 the best option for data integration, because it offers good features for linking and integrating data without violating OWL-DL restrictions. A disadvantage is that it is not aligned with BFO, which may impede integration with data annotated using a BFO-based ontology. Therefore, we retained only the minimal set of classes in GCO. The RDF representation for the model shown in Figure 4C is accessible at http://rdf.biosemantics.org/examples/gco_integration.

Conclusions

We demonstrated a working data model of sequence annotations that can be preserved across different reference sequence assemblies. This data model uses the ontology of Reference Sequence Annotation, which is available at http://purl.bioontology.org/ontology/RSA.

We also demonstrated that within the scope of our model, BFO could not accommodate all instances required for our purpose when we followed the realism constraint defined by BFO and restrict instances to OWL-DL. However, we cannot exclude that different viewpoints towards modeling genome annotations can provide new insights that would fit the current BFO. GCO was created as our best effort to provide interoperability across reference assemblies, which is available at http://purl.bioontology.org/ontology/GCO. The alignment between RSA, GCO, and OBO will be an ongoing effort.

List of abbreviations used

LSDB: 

Locus Specific Databases

LOVD2: 

Leiden Open-source Variation Database v.2

ENCODE: 

ENCyclopedia Of DNA Elements

UCSC: 

University of California, Santa Cruz

BED: 

Browser Extensible Data

RDF: 

Resource Description Framework

OWL: 

Web Ontology Language

OB and BO: 

Open Biological and Biomedical Ontologies

BFO: 

Basic Formal Ontology

IAO: 

Information Artifact Ontology

SO: 

Sequence Ontology

OGI: 

Ontology of Genomic Intervals

RO: 

Relation Ontology

FALDO: 

Feature Annotation Location Description Ontology

RSA: 

Reference Sequence Annotation

IC: 

BFO:independent_continuant

GDC: 

BFO:generically_dependent_continuant

GCO: 

Genome Component Ontology

Declarations

Acknowledgements

The research reported in this paper is supported by the RD-Connect project (contract no. 305444) under EU FP7, the EU Wf4Ever project (270129) funded under EU FP7 (ICT-2009.4.1), the IMI-JU project Open PHACTS, grant agreement no. 115191. This publication was made possible in part through the support of a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. We would like to thank Clifford Tatum for critical editorial review.

Declarations

The publication costs for this article were funded by the RD-Connect project.

This article has been published as part of Journal of Biomedical Semantics Volume 5 Supplement 1, 2014: Proceedings of the Bio-Ontologies Special Interest Group 2013. The full contents of the supplement are available online at http://www.jbiomedsem.com/supplements/5/S1.

Authors’ Affiliations

(1)
Department of Human Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center
(2)
Informatics Institute of the Faculty of Science, University of Amsterdam
(3)
Leiden Genome Technology Center, Leiden University Medical Center
(4)
Department of Rheumatology, Leiden University Medical Center

References

  1. Cotton RGH: Progress of the HUGO Mutation Database Initiative: A brief introduction to the Human Mutation MDI Special Issue. Human Mutation. 2000, 15: 4-6. 10.1002/(SICI)1098-1004(200001)15:1<4::AID-HUMU3>3.0.CO;2-T.View ArticleGoogle Scholar
  2. Fokkema IFAC, Taschner PEM, Schaafsma GCP, Celli J, Laros JFJ, den Dunnen JT: LOVD v.2.0: the next generation in gene variant databases. Human Mutation. 2011, 32: 557-563. 10.1002/humu.21438.View ArticleGoogle Scholar
  3. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PEM: Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Human Mutation. 2008, 29: 6-13. 10.1002/humu.20654.View ArticleGoogle Scholar
  4. Collins FS, Green ED, Guttmacher AE, Guyer MS, Institute USNHGR: A vision for the future of genomics research. Nature. 2003, 422: 835-847. 10.1038/nature01626.View ArticleGoogle Scholar
  5. The Genome Reference Consortium. [http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/index.shtml]
  6. The EPC: A User's Guide to the Encyclopedia of DNA Elements (ENCODE). PLoS Biol. 2011, 9-Google Scholar
  7. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler , David : The Human Genome Browser at UCSC. Genome Res. 2002, 12: 996-1006. 10.1101/gr.229102. Article published online before print in May 2002.View ArticleGoogle Scholar
  8. Sagotsky JA, Zhang L, Wang Z, Martin S, Deisboeck TS: Life Sciences and the web: a new era for collaboration. Molecular systems biology. 2008, 4: 201-View ArticleGoogle Scholar
  9. Marshall MS, Roos M, Meij E, Katrenko S, Hage W, Adriaans P: Semantic Disclosure in an e-Science Environment. Semantic e-Science Edited by Chen H, Wang Y, Cheung K-H: Springer US;. 2010, 11: 29-65. Annals of Information Systems, :Google Scholar
  10. Post LJG, Roos M, Marshall MS, Driel Rv, Breit TM: A semantic web approach applied to integrative bioinformatics experimentation: a biological use case with genomics data. Bioinformatics. 2007, 23: 3080-3087. 10.1093/bioinformatics/btm461.View ArticleGoogle Scholar
  11. Neumann EK, Miller E, Wilbanks J: What the semantic web could do for the life sciences. Drug Discovery Today: BIOSILICO. 2004, 2: 228-236. 10.1016/S1741-8364(04)02420-5.View ArticleGoogle Scholar
  12. Antezana E, Kuiper M, Mironov V: Biological knowledge management: the emerging role of the Semantic Web technologies. Briefings in Bioinformatics. 2009, 10: 392-407. 10.1093/bib/bbp024.View ArticleGoogle Scholar
  13. Patrinos GP, Cooper DN, van Mulligen E, Gkantouna V, Tzimas G, Tatum Z, Schultes E, Roos M, Mons B: Microattribution and nanopublication as means to incentivize the placement of human genome variation data into the public domain. Hum Mutat. 2012, 33: 1503-1512. 10.1002/humu.22144.View ArticleGoogle Scholar
  14. Zappa A, Splendiani A, Romano P: Towards linked open gene mutations data. BMC Bioinformatics. 2012, 13 (Suppl 4): S7-10.1186/1471-2105-13-S4-S7.View ArticleGoogle Scholar
  15. Design Issues: Linked Data. [http://www.w3.org/DesignIssues/LinkedData.html]
  16. Guarino N: Formal Ontology and Information Systems. Formal Ontology in Information Systems: Proceedings of the First International Conference (FOIS'98), Trento, Italy, 6-8 June 1998, of Frontiers in Artificial Intelligence and Applications. 1998, 46: 3-15.Google Scholar
  17. Herre H, Heller B: Semantic Foundations of Medical Information Systems Based on Top-Level Ontologies. Journal of Knowledge-Based Systems. 2006, 19: 107-115. 10.1016/j.knosys.2005.10.002.View ArticleGoogle Scholar
  18. Smith B, Williams J, Schulze-Kremer S: The Ontology of the Gene Ontology. AMIA Annu Symp Proc. 2003Google Scholar
  19. Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, Goldberg LJ, Eilbeck K, Ireland A, Mungall CJ: The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotech. 2007, 25: 1251-1255. 10.1038/nbt1346.View ArticleGoogle Scholar
  20. Grenon P, Smith B, Goldberg L: Biodynamic ontology: applying BFO in the biomedical domain. Studies in health technology and informatics. 2004, 102: 20-38.Google Scholar
  21. Information Artifact Ontology. [https://code.google.com/p/information-artifact-ontology]
  22. Eilbeck K, Lewis SE, Mungall CJ, Yandell M, Stein L, Durbin R, Ashburner M: The Sequence Ontology: a tool for the unification of genome annotations. Genome Biology. 2005, 6:Google Scholar
  23. Genome, Gene, Interval and Ontology. [https://code.google.com/p/ontology-for-genetic-interval]
  24. Smith B, Ceusters W, Klagges B, Köhler J, Kumar A, Lomax J, Mungall C, Neuhaus F, Rector AL, Rosse C: Relations in biomedical ontologies. Genome Biology. 2005, 6:Google Scholar
  25. Mungall CJ, Batchelor C, Eilbeck K: Evolution of the Sequence Ontology terms and relationships. Journal of Biomedical Informatics. 2011, 44: 87-93. 10.1016/j.jbi.2010.03.002.View ArticleGoogle Scholar
  26. Hoehndorf R, Kelso J, Herre H: The ontology of biological sequences. BMC Bioinformatics. 2009, 10:Google Scholar
  27. Bada M, Eilbeck K: Efforts toward a More Consistent and Interoperable Sequence Ontology. International Conference on Biomedical Ontology;2012.
  28. Bolleman J, Mungall CJ, Strozzi F, Baran J, Dumontier M, Bonnal RJP, Buels R, Hoehndorf R, Fujisawa T, Katayama T, Cock PJA: FALDO: A semantic standard for describing the location of nucleotide and protein feature annotation. bioRxiv. 2014Google Scholar
  29. Marshall MS, Post L, Roos M, Breit TM: Using Semantic Web Tools to Integrate Experimental Measurement Data on Our Own Terms. On the Move to Meaningful Internet Systems 2006: OTM 2006 Workshops. Edited by: Meersman R, Tari Z, Herrero P. 2006, Springer Berlin Heidelberg, 679-688. Lecture Notes in Computer ScienceView ArticleGoogle Scholar
  30. Dumontier M, Hoehndorf R: Realism for scientific ontologies.International Conference on Formal Ontology in Information Systems. 2010, 387-399.Google Scholar

Copyright

© Tatum et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement